pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 28·1 min read
save

Trump administration proposes four-year visa cap for foreign PhD students and postdocs, sparking science community concerns

Jul 28, 2026·read at STAT ↗RegulatoryNegative

The Department of Homeland Security announced a new rule that limits the stay of international graduate students and postdoctoral researchers in the United States to four years on nonimmigrant visas. Anyone wishing to remain longer must obtain a separate extension from DHS.

The policy takes effect on September 15 and applies to new arrivals. Individuals already in the country who are scheduled to finish their training before September 2030 will not need an extension, even if they have been in the U.S. for more than four years.

Researchers and university officials warned that the change could deter talented foreign scientists from coming to the U.S., potentially weakening the nation’s biomedical research pipeline. They argue that the “forever student” narrative does not reflect the reality of most trainees.

For nearly fifty years, U.S. immigration policy has allowed foreign scholars to stay for the full duration of their programs, regardless of length. The proposed limitation marks a significant shift from that long‑standing approach.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn”

read at STAT ↗
1,338 words · retrieved Jul 28
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Gossamer Bio, Inc.2
topics
ApprovalOphthalmologyPeptide Therapeutic

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jul 20Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide makerBioPharma Dive
  • Jul 16Merck wins first approval of a PCSK9 cholesterol pillBioPharma Dive
  • Jul 14Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugsBioPharma Dive
  • Jul 7Oberland pours up to $400M into MeiraGTx eye gene therapiesBioPharma Dive